InsidersTradesSigma
Discover the full record of transactions filed by Poirier Michael S., 董事长兼首席执行官. Insider active across 1 company, notably Qualigen Therapeutics, Inc.. Aggregated, 1 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €16k. Activity tracked since 22 June 2022. The latest transaction was filed on 22 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Michael S. Poirier is the Chairman & CEO of Qualigen Therapeutics, Inc. He is responsible for the strategic direction of the company and the implementation of its vision. His experience in the biopharmaceutical sector is essential for guiding the organization towards sustainable growth.